Media Kit

Leveraging Sona’s uniquely biocompatible gold nanorods as immunomodulators to stimulate the immune system creating new immunity that can empower immuno-oncology therapies ​

Leveraging Sona’s uniquely biocompatible gold nanorods as immunomodulators to stimulate the immune system creating new immunity that can empower immuno-oncology therapies

Download our Brand Assets kit, including logos, leadership and project images

Company Overview, Contact Details, Leadership Bio & Project Summary

Research Group

Evaluation of SONA’s Gold Nanoparticle-Mediated Photothermal Therapy in Combination with Intralesional Immune Modulation as a novel Immuno-Oncology strategy for Colorectal Cancers, Skin Cancers and Breast Cancers.

Whitepapers & Publications

Latest News

Sona Nanotech to Present at the OTC Markets’ Life Sciences Virtual Investor Forum On September 17th (1)
September 11, 2026

Sona Nanotech to Present at the OTC Markets’ Life Sciences Virtual Investor Forum On September 17th